White Papers

This white paper presents an analysis of the RAS inhibitor landscape, with views based on structural similarity, chemical properties, and patent assignees. See what the insights reveal.

This CAS whitepaper explores the transformation of IP and R&D, where organizations apply IP insights to accelerate breakthroughs and identify potential risks to commercialization earlier in the product lifecycle.

This whitepaper discusses how pharmaceutical companies can maximize the strategic value of formulations data to shorten development times, stay ahead of competition, and position themselves for success.

Emerging Trends in Drug Delivery is a CAS whitepaper which highlights four technologies that have shown particular growth in recent years and are expected to be key innovation areas in the future.

Download this CAS whitepaper and learn five often overlooked IP gaps that can hinder innovation strategy.

Vaccines are a cost-effective and durable medical strategy for disease prevention in public health efforts worldwide. As the focus of medicine expands from disease treatment to disease prevention, the vaccine industry should witness even more rapid development. This CAS whitepaper looks at key R&D trends.

This CAS white paper identifies major trends in gene and cell therapy R&D that may help to predict future developments and pinpoint opportunities for therapeutic applications in the treatment of various diseases.

With rapid advances in recombinant DNA and protein engineering technologies, therapeutic fusion proteins have emerged as a new option for biologics with improved pharmacokinetic stability and enhanced capability to act on molecular targets. Fusion proteins have also facilitated the development of new vaccines, and gene and cell therapy drugs to address other clinical challenges.

After decades of research and development, antibody-based drugs are now the fastest growing class of therapeutic agents. This whitepaper identifies four major trends that may help to predict future R&D efforts.